Full Text
Cost Effectiveness of Nivolumab Monotherapy for the Treatment of Advanced Melanoma Patients in the United Kingdom

Abstract

Authors

Y Meng N Hertel J Ellis H Johnson Z Philips N Roskell D Lee

Back to Volume 19, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×